Beyond the peptide category

NAD+

A nucleotide coenzyme involved in cellular metabolism. NAD+ is not a peptide.

Non-peptide compounds · Educational information only · No medical advice

← Peptide library · Start Here

All related compounds

Non-peptide coenzyme

Also discussed as: Nicotinamide adenine dinucleotide

What it is and how it works

NAD+ and its reduced form, NADH, participate in cellular oxidation-reduction reactions. Its normal role in cells explains scientific interest, but does not establish that administering a commercial NAD+ product improves energy or reverses aging.

Source for this context →

A closer look at the cited evidence

Biology + safety context

This label describes the selected source below. It is not a complete ranking of the literature, a safety score, or an approval status.

Study or assessment
FDA — ingredients suitable for sterile compounding
Design
Regulatory safety communication, not a wellness effectiveness trial.
Who or what was studied
Reports associated with compounded NAD+ injectable products.
What was observed
FDA received reports of severe chills, shaking, vomiting, and fatigue, with some requiring medical treatment.
Limits of interpretation
Reports do not determine every event’s cause or establish effectiveness. Oral precursors and intravenous NAD+ are distinct products.
Read the cited study or assessment →

Regulatory context

A normal cellular role does not confer FDA approval for an anti-aging infusion. A compounded product is not FDA approved.

Safety considerations

Sterile-product quality is a separate safety question from a molecule’s biological function. Research-use or supplement-grade material cannot establish suitability for an injectable drug.

What remains uncertain

Evidence about a precursor supplement cannot automatically answer questions about NAD+ infusions. A useful study would need to specify the product, route, population, clinical outcome, and adverse events.

Sources

Start Your Assessment